Are there any adverse reactions?
Autologous transplant of SVF AT-ASCs also poses
extremely low risk to the patient when done as a single procedure in a sterile
surgical operating room setting. Furthermore, it is postulated that SVF AT-ASCs
due to their immunosuppressive properties may be transplanted into not only autologous
but also allogenic tissues without initiating a cytotoxic T-cell response.
However, Autologous transplants are believed to be the safest and most viable
option at this point.